Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer

Attila Keresztes1, John M Streicher1

  • 1Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

FEBS Letters
|September 27, 2017
PubMed

Insights

Cannabinoids and death receptor ligands synergize to enhance cancer cell death. This review explores their combined potential for treating malignancies.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Cannabinoid receptors interact with tumor necrosis factor receptor superfamily (TNFRS) members.
  • This interaction can induce cancer cell death.
  • Cannabinoids and death receptor ligands show synergistic antitumor effects in vitro.

Purpose of the Study:

  • To review the interaction between cannabinoid and death receptor (DR) systems.
  • To explore the potential of combining cannabinoids with DR ligands for cancer therapy.

Main Methods:

  • Literature review of studies on cannabinoid-TNFRS interactions.
  • Analysis of in vitro data on combined cannabinoid and DR ligand administration.
  • Synthesis of findings on synergistic effects in cancer cell death.

Main Results:

  • Cannabinoids sensitize cancer cells to DR ligands.
  • Combined administration of cannabinoids and DR ligands enhances antitumor activity.
  • Evidence suggests additive or synergistic tumor cell death.

Conclusions:

  • The cannabinoid and DR systems interact to induce cancer cell death.
  • Co-application of cannabinoids and DR ligands is a promising strategy for treating various malignancies.
  • Further clinical research is warranted to validate this therapeutic approach.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
816
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.1K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K